Fursultiamine

Fursultiamine

Clinical data
AHFS/Drugs.com	International Drug Names
Routes of administration	Oral
ATC code	None
Legal status
Legal status	In general: Over-the-counter (OTC)
Identifiers
IUPAC name N-[(4-Amino-2-methylpyrimidin-5-yl)methyl]-N-{(1E)-4-hydroxy-1-methyl-2-[(tetrahydrofuran-2-ylmethyl)disulfanyl]but-1-en-1-yl}formamide
CAS Number	804-30-8
PubChem CID	3002119
DrugBank	DB08966 N
ChemSpider	2273321
UNII	05J61265PX
ChEMBL	ChEMBL1740659
CompTox Dashboard (EPA)	DTXSID0023084
ECHA InfoCard	100.011.234
Chemical and physical data
Formula	C17H26N4O3S2
Molar mass	398.54 g·mol−1
3D model (JSmol)	Interactive image
SMILES O=CN(\C(=C(\SSCC1OCCC1)CCO)C)Cc2cnc(nc2N)C

Fursultiamine (INN; chemical name thiamine tetrahydrofurfuryl disulfide or TTFD; brand names Adventan, Alinamin-F, Benlipoid, Bevitol Lipophil, Judolor, Lipothiamine) is a medication and vitamin used to treat thiamine deficiency. Chemically, it is a disulfide derivative of thiamine and is similar in structure to allithiamine.

It was synthesized in Japan in the 1960s from allithiamine for the purpose of developing forms of thiamine with improved lipophilicity for treating vitamin B₁ deficiency (i.e., beriberi), It was subsequently commercialized not only in Japan but also in Spain, Austria, Germany, and the United States.

See also

• Vitamin B₁ analogue

Further reading

• Lonsdale D (September 2004). "Thiamine tetrahydrofurfuryl disulfide: a little known therapeutic agent". Medical Science Monitor. 10 (9): RA199–203. PMID 15328496.